X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4577) 4577
Book Review (703) 703
Publication (253) 253
Conference Proceeding (53) 53
Dissertation (6) 6
Book Chapter (5) 5
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3324) 3324
humans (3134) 3134
oncology (3057) 3057
radiotherapy (2377) 2377
female (2354) 2354
middle aged (2121) 2121
concurrent chemoradiotherapy (2040) 2040
chemotherapy (2022) 2022
aged (1948) 1948
cancer (1886) 1886
male (1862) 1862
adult (1656) 1656
radiation-therapy (1416) 1416
chemoradiotherapy (1284) 1284
treatment outcome (1128) 1128
care and treatment (1075) 1075
cisplatin (1067) 1067
concurrent chemotherapy (1035) 1035
neoplasm staging (991) 991
combined modality therapy (927) 927
radiology, nuclear medicine & medical imaging (890) 890
carcinoma (885) 885
squamous-cell carcinoma (873) 873
retrospective studies (858) 858
antineoplastic combined chemotherapy protocols - therapeutic use (843) 843
surgery (843) 843
survival (782) 782
aged, 80 and over (721) 721
prognosis (715) 715
radiation (673) 673
disease-free survival (665) 665
radiation therapy (658) 658
hematology, oncology and palliative medicine (637) 637
cisplatin - administration & dosage (606) 606
induction chemotherapy (601) 601
chemoradiation (595) 595
survival rate (588) 588
randomized-trial (583) 583
trial (530) 530
radiotherapy dosage (527) 527
research (510) 510
cervical cancer (506) 506
analysis (493) 493
therapy (487) 487
nasopharyngeal carcinoma (477) 477
survival analysis (475) 475
patients (474) 474
toxicity (470) 470
carcinoma, squamous cell - radiotherapy (467) 467
follow-up studies (461) 461
carcinoma, squamous cell - pathology (460) 460
squamous cell carcinoma (456) 456
carcinoma, squamous cell - therapy (455) 455
concurrent (440) 440
intensity-modulated radiotherapy (436) 436
head and neck cancer (422) 422
medicine & public health (413) 413
carcinoma, squamous cell - drug therapy (403) 403
phase-iii (402) 402
neck-cancer (401) 401
antineoplastic agents - therapeutic use (385) 385
chemoradiotherapy - methods (374) 374
lung neoplasms - radiotherapy (374) 374
lung neoplasms - pathology (362) 362
carcinoma, squamous cell - mortality (358) 358
health aspects (354) 354
locally advanced head (354) 354
otorhinolaryngology (344) 344
concurrent chemoradiation (330) 330
fluorouracil - administration & dosage (330) 330
adjuvant chemotherapy (329) 329
cancer therapies (325) 325
patient outcomes (321) 321
carcinoma, non-small-cell lung - radiotherapy (320) 320
carcinoma, non-small-cell lung - pathology (313) 313
lung neoplasms - drug therapy (311) 311
head and neck neoplasms - radiotherapy (304) 304
phase-ii (304) 304
metastasis (297) 297
lung cancer, non-small cell (295) 295
phase-iii trial (293) 293
lung cancer (291) 291
uterine cervical neoplasms - pathology (291) 291
kaplan-meier estimate (289) 289
respiratory system (283) 283
chemoradiotherapy - adverse effects (281) 281
head and neck neoplasms - drug therapy (280) 280
antineoplastic combined chemotherapy protocols - adverse effects (277) 277
esophageal cancer (277) 277
radiology (275) 275
risk factors (275) 275
carcinoma, non-small-cell lung - drug therapy (272) 272
head (271) 271
lung neoplasms - therapy (271) 271
chemotherapy, adjuvant (270) 270
docetaxel (260) 260
phase-ii trial (256) 256
prospective studies (254) 254
tumors (254) 254
young adult (251) 251
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4456) 4456
French (55) 55
Korean (45) 45
Japanese (35) 35
German (19) 19
Czech (6) 6
Chinese (5) 5
Polish (5) 5
Spanish (4) 4
Turkish (2) 2
Hungarian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 20, pp. 1919 - 1929
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 24, pp. 2342 - 2350
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 4, pp. 317 - 326
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 1, pp. 59 - 68
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 75, pp. 14 - 23
Abstract Background The role of neoadjuvant chemotherapy (NACT) for locoregionally advanced nasopharyngeal carcinoma (NPC) is unclear. We aimed to evaluate the... 
Hematology, Oncology and Palliative Medicine | Neoadjuvant chemotherapy | Locoregionally advanced nasopharyngeal carcinoma | Concurrent chemoradiotherapy | Randomised controlled trial | ADJUVANT CHEMOTHERAPY | HEAD | METAANALYSIS | PROGRESSION-FREE SURVIVAL | TUMORS | PUBLISHED LITERATURE | NECK-CANCER | THERAPY | ONCOLOGY | CISPLATIN-RADIOTHERAPY | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Male | Cisplatin - administration & dosage | Feasibility Studies | Young Adult | Neoplasm Metastasis | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Adult | Female | Neutropenia - chemically induced | Chemoradiotherapy - methods | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms - therapy | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Aftercare | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Adolescent | Cisplatin - adverse effects | Carcinoma - therapy | Infusions, Intravenous | Prevention | Medical colleges | Carcinoma | Adjuvant treatment | Radiation | Clinical trials | Cancer | Statistical analysis | Toxicity | Feasibility studies | Feasibility analysis | Radiation therapy | Throat cancer | Patients | Survival | Cisplatin | Metastases | Rank tests | Nasopharyngeal carcinoma | Chemotherapy | Platinum | Significance | Neutropenia | Tumors | Index Medicus
Journal Article
Cancer Science, ISSN 1347-9032, 04/2015, Volume 106, Issue 4, pp. 407 - 412
Journal Article
STRAHLENTHERAPIE UND ONKOLOGIE, ISSN 0179-7158, 08/2015, Volume 191, Issue 8, pp. 635 - 641
Purpose Concurrent chemoradiotherapy (CRT) is the standard treatment for advanced head and neck squamous cell carcinoma. In this phase II randomized study, the... 
Induction chemotherapy | CONCOMITANT CHEMORADIOTHERAPY | TPF | FLUOROURACIL | Chemoradiotherapy | RADIATION-THERAPY | TRIAL | PRESERVATION | ONCOLOGY | Head and neck cancer | Randomized trial | LOCALLY ADVANCED HEAD | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CONCURRENT CHEMORADIOTHERAPY
Journal Article